Table 1 The basic characteristics of the AECOPD group, stable COPD, heavy—smoking group, and healthy control group.
From: Diagnostic and prognostic value of serum miR-155 in chronic obstructive pulmonary disease
AECOPD(n = 29) | stable COPD (n = 30) | heavy- smoking (n = 31) | healthy control (n = 27) | p | |
|---|---|---|---|---|---|
Age | 70.03 ± 8.11 | 69.57 ± 6.76 | 67.52 ± 7.72 | 67.44 ± 6.70 | 0.053 |
Sex | |||||
Male, n (%) | 27(93.1%) | 28(93.3%) | 28(90.3%) | 21(77.8%) | 0.169 |
Female, n (%) | 2(6.9%) | 2(6.7%) | 3(9.7%) | 6(22.2%) | |
BMI | 23.38 ± 2.88 | 22.80 ± 2.61 | 23.74 ± 2.40 | 24.51 ± 2.36 | 0.092 |
Smoking status | |||||
Never, n (%) | 0(0%) | 0(0%) | 0(0%) | 27(100%) | |
Former, n (%) | 24(82.75%) | 22(73.33%) | 0(0%) | 0(0%) | 0.000 |
Current, n (%) | 5(17.24%) | 8(26.67%) | 31(100%) | 0(0%) | |
FEV1%pred | 30.0 (25.7, 43.6)*#& | 65.7(40.9, 86.1)*# | 101.5(91.8, 112.3) | 97.5(87.0, 109.5) | 0.000 |
Comorbidities | |||||
Cardiovascular disease, n (%) | 10(34.5%) | 4(13.3%) | 5(16.1%) | 4(14.8%) | 0.142 |
Cerebrovascular disease, n (%) | 2(6.9%) | 0(0.0%) | 1(3.2%) | 2(7.4%) | 0.300 |
Diabetes mellitus, n (%) | 4(13.8%) | 4(13.3%) | 4(12.9%) | 4(14.8%) | 0.997 |
Connective tissue disease, n (%) | 1(3.4%) | 1(3.3%) | 1(3.2%) | 2(7.4%) | 0.862 |
Gastroesophageal reflux, n (%) | 2(6.9%) | 1(3.3%) | 1(3.2%) | 2(7.4%) | 0.822 |
GOLD stages | |||||
I, n (%) | 3(10.3%) | 7(23.3%) | 0.299 | ||
II, n (%) | 2(6.9%) | 8(26.7%) | 0.080 | ||
III, n (%) | 11(37.9%) | 6(20.0%) | 0.158 | ||
IV, n (%) | 13(44.8%) | 9(30.0%) | 0.288 | ||
ABE groups | |||||
A, n (%) | 2(6.9%) | 6(20.0%) | 0.254 | ||
B, n (%) | 8(29.6%) | 11(36.7%) | 0.779 | ||
E, n (%) | 19(65.5%) | 13(43.3%) | 0.087 | ||
